Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Shanghai Pharmaceuticals Holding Co., Ltd
Tianjin Medical University Cancer Institute and Hospital
City of Hope Medical Center
Shandong Cancer Hospital and Institute
Children's National Research Institute
North Eastern German Society of Gynaecological Oncology
Dana-Farber Cancer Institute
Eisai Inc.
Australasian Leukaemia and Lymphoma Group
Charite University, Berlin, Germany
Sunnybrook Health Sciences Centre
Peking Union Medical College Hospital
Centre Hospitalier Universitaire, Amiens
Grupo Espanol de Investigacion en Sarcomas
Institut Bergonié
Masonic Cancer Center, University of Minnesota
Celldex Therapeutics
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Sarcoma Alliance for Research through Collaboration
Roswell Park Cancer Institute
University of Maryland, Baltimore
Roswell Park Cancer Institute
University of Chicago
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Novartis
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Duke University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Michigan Rogel Cancer Center
National Cancer Center, Korea
Dana-Farber Cancer Institute
Children's Oncology Group
University of South Florida
University of South Florida
National Cancer Institute (NCI)